Save your place

Sign in to WhoBought

Please try again later.

MBX Biosciences, Inc. Common Stock (MBX) institutional ownership

Latest close $62.00 Jul 24, 2026
Market cap$336M 52-week range SectorHealthcare
Funds holding · Q1 2026
141
reported MBX position changes
Top owners · Q1 2026
No disclosed owners are available.
Institutional activity · Q1 2026
Net bought $140M
76 buyers · 65 sellers

MBX Biosciences, Inc. Common Stock (MBX) price and institutional activity

Dates

Q1 2026

$328M bought by 76 investors
FMR LLC$99MPolar Capital Holdings PLC$55M +74 more
$188M sold by 65 investors
Ecor1 Capital, LLC-$46MPoint72 Asset Management, L.P.-$23M +63 more
Bought Sold Totals per quarter; hover a bar for the names.

MBX Biosciences, Inc. Common Stock (MBX) institutional activity · 141

Investor Type Est. change Change Δ Own Date
FMR LLC · Added +$99M
Change +2.9M Δ Own +18550.3% Date Q1 2026
FMR LLC Added· Q1 2026 +$99M +2.9M +18550.3% Q1 2026
Polar Capital Holdings PLC · New +$55M
Change +1.6M Date Q1 2026
Polar Capital Holdings PLC New· Q1 2026 +$55M +1.6M Q1 2026
Ecor1 Capital, LLC · Reduced −$46M
Change −1.3M Date Q1 2026
Ecor1 Capital, LLC Reduced· Q1 2026 −$46M −1.3M Q1 2026
Aaron Wealth Advisors LLC · Added +$37M
Change +1.1M Date Q1 2026
Aaron Wealth Advisors LLC Added· Q1 2026 +$37M +1.1M Q1 2026
Caligan Partners LP · New +$29M
Change +849K Date Q1 2026
Caligan Partners LP New· Q1 2026 +$29M +849K Q1 2026
Point72 Asset Management, L.P. · Exited −$23M
Change −681K Δ Own −100.0% Date Q1 2026
Point72 Asset Management, L.P. Exited· Q1 2026 −$23M −681K −100.0% Q1 2026
Deep Track Capital, LP · Reduced −$17M
Change −492K Date Q1 2026
Deep Track Capital, LP Reduced· Q1 2026 −$17M −492K Q1 2026
Braidwell LP · Added +$16M
Change +474K Date Q1 2026
Braidwell LP Added· Q1 2026 +$16M +474K Q1 2026
Stempoint Capital LP · Added +$14M
Change +421K Date Q1 2026
Stempoint Capital LP Added· Q1 2026 +$14M +421K Q1 2026
Driehaus Capital Management LLC · Reduced −$13M
Change −390K Date Q1 2026
Driehaus Capital Management LLC Reduced· Q1 2026 −$13M −390K Q1 2026
D. E. Shaw & Co., Inc. · Reduced −$13M
Change −383K Δ Own −57.0% Date Q1 2026
D. E. Shaw & Co., Inc. Reduced· Q1 2026 −$13M −383K −57.0% Q1 2026
Trails Edge Capital Partners, LP · Exited −$11M
Change −315K Δ Own −100.0% Date Q1 2026
Trails Edge Capital Partners, LP Exited· Q1 2026 −$11M −315K −100.0% Q1 2026
Orbimed Advisors LLC · Reduced −$10M
Change −297K Date Q1 2026
Orbimed Advisors LLC Reduced· Q1 2026 −$10M −297K Q1 2026
Candriam S.c.a. · New +$10M
Change +294K Date Q1 2026
Candriam S.c.a. New· Q1 2026 +$10M +294K Q1 2026
Soleus Capital Management, L.P. · Reduced −$7.8M
Change −230K Date Q1 2026
Soleus Capital Management, L.P. Reduced· Q1 2026 −$7.8M −230K Q1 2026
Data through Q1 2026 · filed Jun 2, 2026
15 of 141

Famous investor activity in MBX Biosciences, Inc. Common Stock (MBX)

MBX Biosciences, Inc. Common Stock (MBX) insider trading

Company insiders, action and economics first; trade and filed dates last.
Dates
Insider Title Type Price Qty Value Owned ΔOwn Trade date Filed date
Mathers Edward T. · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Mathers Edward T. Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Pescovitz Ora H. · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Pescovitz Ora H. Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Heron Patrick J. · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Heron Patrick J. Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Stelzer Laurie · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Stelzer Laurie Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Hoerter Steven L. · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Hoerter Steven L. Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Ryder Steven · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Ryder Steven Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Aynechi Tiba · Director Grant (A) 12K
Owned 12K Trade date Jun 4, 2026 Filed date Jun 5, 2026
Aynechi Tiba Director Grant (A) 12K 12K Jun 4, 2026 Jun 5, 2026
Azoulay Salomon · Officer 2 operations −$2.7M
Price $38.30–$38.38 Qty −70K Owned 15K Trade date May 8, 2026 Filed date May 11, 2026
Azoulay Salomon Officer 2 operations $38.30–$38.38 −70K −$2.7M 15K May 8, 2026 May 11, 2026
Azoulay Salomon · Officer 4 operations 140K
Price $10.46–$16.00 Owned 30K Trade date May 8, 2026 Filed date May 11, 2026
Azoulay Salomon Officer 4 operations $10.46–$16.00 140K 30K May 8, 2026 May 11, 2026
Azoulay Salomon · Officer Sell −$7K
Price $29.54 Qty −231 Owned 15K Trade date May 6, 2026 Filed date May 8, 2026
Azoulay Salomon Officer Sell $29.54 −231 −$7K 15K May 6, 2026 May 8, 2026
Hawryluk P. Kent · Director Sell −$18K
Price $29.54 Qty −607 Owned 728K Trade date May 6, 2026 Filed date May 8, 2026
Hawryluk P. Kent Director Sell $29.54 −607 −$18K 728K May 6, 2026 May 8, 2026
Hoerter Steven L. · Director 2 operations 86K
Owned 74K Trade date May 1, 2026 Filed date May 4, 2026
Hoerter Steven L. Director 2 operations 86K 74K May 1, 2026 May 4, 2026
Hawryluk P. Kent · Director, Officer Buy +$526K
Price $28.41 Qty +18K Owned 487K Trade date Mar 13, 2026 Filed date Mar 16, 2026
Hawryluk P. Kent Director, Officer Buy $28.41 +18K +$526K 487K Mar 13, 2026 Mar 16, 2026
Hawryluk P. Kent · Director, Officer 2 operations 0
Price $16.00 Owned 92K Trade date Feb 26, 2026 Filed date Feb 27, 2026
Hawryluk P. Kent Director, Officer 2 operations $16.00 0 92K Feb 26, 2026 Feb 27, 2026
Azoulay Salomon · Officer 2 operations 85K
Owned 70K Trade date Feb 2, 2026 Filed date Feb 3, 2026
Azoulay Salomon Officer 2 operations 85K 70K Feb 2, 2026 Feb 3, 2026
15 of 24
15 of 24 Sign in to continue to older insider transactions.

MBX Biosciences, Inc. Common Stock (MBX) activist and large shareholders

Dates
Owner/Filer identity Shares reported % of shares outstanding Filing date
FMR LLC 5.3M
% of shares outstanding 11.2% Filing date Jul 8, 2026
FMR LLC 5.3M 11.2% Jul 8, 2026
Wellington Management Group LLP 5.0M
% of shares outstanding 10.5% Filing date Jul 8, 2026
Wellington Management Group LLP 5.0M 10.5% Jul 8, 2026
Hawryluk P. Kent 1.9M
% of shares outstanding 5.5% Filing date Nov 1, 2024
Hawryluk P. Kent 1.9M 5.5% Nov 1, 2024
Paradigm Biocapital Advisors LP 2.5M
% of shares outstanding 5.2% Filing date Jun 24, 2026
Paradigm Biocapital Advisors LP 2.5M 5.2% Jun 24, 2026
Blackrock, Inc. 2.3M
% of shares outstanding 4.8% Filing date Apr 27, 2026
Blackrock, Inc. 2.3M 4.8% Apr 27, 2026
5 of 5

MBX Biosciences, Inc. Common Stock (MBX) ownership FAQ

Who owns MBX?

141 reporting institutions disclosed MBX position changes in the Q1 2026 snapshot.

How is institutional activity calculated?

For each manager, WhoBought compares accepted consecutive 13F share counts. Share change is current shares minus prior shares. Estimated dollar change is that signed share change multiplied by the split-adjusted quarter-mean close. The activity table on this page uses Q1 2026.

What are activist and large shareholder filings?

An investor crossing 5% of a share class generally files Schedule 13D for activist intent or Schedule 13G for a passive position. The technical form names appear here rather than in the activity rows.

Where does this data come from?

Ownership and institutional activity come from SEC Form 13F filings. Insider activity comes from SEC Form 4, and large-shareholder activity from SEC Schedules 13D and 13G. FMP supplies price data only. Company logos use the local verified Parqet cache with one shared fallback.

Why are ownership reports delayed?

Form 13F is a quarterly disclosure and is normally filed after the quarter ends. Every ownership and activity value therefore names its represented period; it is not presented as a live position.

How are missing table values shown?

A muted dash marks a missing table value. It means the filing omitted the value, comparable data is unavailable, or no prior position exists for comparison.